Who to call at Phreesia, and when

Fundz watches for the moments Phreesia starts buying, and tells you who to reach.

An alert the day Phreesia raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Phreesia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Phreesia. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Phreesia Renews Contract with CMS for Patient Activation Measure (PAM)

Oct 01, 2024

Contract Type

contract

New YorkInformation TechnologyBiotechnologyHealthcareHealth CareMedical

Description

Phreesia has renewed its contract with the CMS Innovation Center (CMMI) for use of the Patient Activation Measure® (PAM) through 2029. The PAM performance measure assesses gains in patients’ knowledge, skills and confidence in managing their own healthcare. Under the new contract, Phreesia will provide access to PAM, training, analysis, and other support to the Kidney Care Choices Model (KCC).

Company Information

Company

Phreesia

Location

432 PARK AVENUE S.

New York, New York, United States

About

Phreesia is the trusted leader in patient activation, giving providers, health plans, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 120 million patient visits in 2022–more than 1 in 10 visits across the U.S.–scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.